In SURPASS-AP trial insulin-naive diabetic patients not adequately controlled on therapy with metformin (with or without a sulphonylurea) in Australia, India, China and South Korea, were randomized to TZP 5 mg, 10 mg or 15 mg or insulin glargine
Take our 2-minute assessment
A comprehensive GLP-1 supplement strategy that covers these common gaps can address a subtle but meaningful contributor to stalls
Although drug injections have been administered in a similar manner for a long time, the guideline for drug injection has been continuously updated based on clinical trials for better treatment with overcoming technical limitations 1, 2, 6,7,8,9
Mitochondria as targets in angiogenesis inhibition